Analysis of patients’ side effects and quality of life in the ADAURA study
This video article presents the phase III ADAURA study investigating osimertinib in the treatment of early-stage EGFR-mutated NSCLC.
Authors
- Thomas John (ORCID: https://orcid.org/0000-0003-3399-5342)
Institutions
- Peter MacCallum Cancer Centre (AU)
Publication Details
- Journal
- Video Journal of Biomedicine
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1080/vjbm-2023-0012
- Primary Topic
- Psychological Treatments and Assessments
- Type
- article
- Field-Weighted Citation Impact
- 0.00